-
Signature
-
/s/ Lisa P. Wang, Attorney-In-Fact
-
Issuer symbol
-
FTI
-
Transactions as of
-
09 Mar 2026
-
Net transactions value
-
-$10,699,160
-
Form type
-
4
-
Filing time
-
11 Mar 2026, 16:17:02 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Rounce Justin |
EVP & Chief Technology Officer |
C/O TECHNIPFMC PLC, HADRIAN HOUSE, WINCOMBLEE ROAD, NEWCASTLE UPON TYNE, UNITED KINGDOM |
/s/ Lisa P. Wang, Attorney-In-Fact |
11 Mar 2026 |
0001754857 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
FTI |
Ordinary Shares |
Options Exercise |
|
+39,108 |
+15% |
$16.47* |
291,943 |
09 Mar 2026 |
Direct |
F1 |
| transaction |
FTI |
Ordinary Shares |
Sale |
$3,101,388 |
-50,668 |
-17% |
$61.21 |
241,275 |
09 Mar 2026 |
Direct |
F1, F2 |
| transaction |
FTI |
Ordinary Shares |
Sale |
$4,709,526 |
-75,850 |
-31% |
$62.09 |
165,425 |
09 Mar 2026 |
Direct |
F1, F3 |
| transaction |
FTI |
Ordinary Shares |
Sale |
$2,888,245 |
-45,758 |
-28% |
$63.12 |
119,667 |
09 Mar 2026 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
FTI |
Employee Stock Option (right to buy) |
Options Exercise |
|
-39,108 |
-100% |
$0.000000* |
0 |
09 Mar 2026 |
Ordinary Shares |
39,108 |
$16.47 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: